Brooks Laboratories has announced a board meeting to discuss various corporate matters, including the financial results for the quarter and half-year. In compliance with SEBI regulations, the company has received a confirmation certificate from MUFG Intime India, its Registrar and Share Transfer Agent, regarding the successful dematerialization of securities for the quarter ended 31st December 2024. Notably, there were no demat or remat requests during this period. This update reflects the company's operational efficiency and may instill confidence among investors, indicating stable management of share transactions.